Our Approach
City of Hope is one of the largest and most successful treatment centers in the country for patients with lymphoma. Because of our vast experience in treating patients with this type of cancer, our specialists lead the field of hematopoietic cell transplantation (HCT) with excellent outcomes. Since 1976, City of Hope has performed more than 11,000 transplants for patients from virtually every state and around the world. 
As one of a handful of institutes to attain the elite designation of Comprehensive Cancer Center by the National Cancer Institutes, City of Hope is acknowledged as a leader in cancer research and treatment.  We collaborate with scientists at City of Hope and other nationally recognized research institutions to develop tomorrow’s breakthrough treatments today. With our extensive program of clinical trials, newly diagnosed or relapsed lymphoma patients can find a clinical trial targeted to their condition at City of Hope.

A Commitment to Create
At City of Hope, we also create new treatments for lymphoma. We pioneered “mini” hematopoietic cell transplants that allow for transplantation in older lymphoma patients.  We offer the broadest range of therapeutic options available, including protocols developed here at City of Hope and funded in part by the National Institutes of Health. Through ongoing clinical trials, our physicians and researchers continue to lead the way in improving outcomes in lymphoma patients. Learn more about our clinical trials.